A plot of change in average tumor size (mm³) vs. time in (days) of treatment in EMT-6/CPR cell line.

 
 
  Part of: Hamed RA, Talib WH (2024) Targeting cisplatin resistance in breast cancer using a combination of Thymoquinone and Silymarin: an in vitro and in vivo study. Pharmacia 71: 1-19. https://doi.org/10.3897/pharmacia.71.e117997